Background: Determination of biomarkers can assess cardiac injury induced by cardiopulmonary bypass (CPB) during coronary artery bypass grafting (CABG). Open heart surgery initiates inflammatory reaction. Aim of this study was to compare the inflammatory response in patients undergoing first-and CABG-reoperation. Methods: Fifty-four patients (16% female, 84% male; 60.5 ± 6.5 vs. 66.2 ± 7.3 years) scheduled for elective cardiac surgery were divided into: Group 1, CABG primo-operation, and Group 2, CABG re-operation (redo CABG). The extent of inflammation was estimated by measuring interleukin (IL)-6 and highly sensitive C-reactive protein (hs-CRP) in plasma. Blood samples were collected: 24 hours prior, 6, and 24 hours after initiation of CPB. Demographic data, preoperative risk assessment Euro-score, laboratory values and clinical outcomes: atrial fibrillation rate, tracheal intubation time, revisions, blood loss, length of Intensive Care Unit (ICU) and hospital stay were analyzed. Results: Baseline levels of IL-6 (p < 0.001) were significantly higher in re-operated patients. IL-6 increased significantly 6 hours after initiation of CPB in both groups (p < 0.0001). Day after surgery IL-6 (p = 0.472) and hs-CRP (p = 0.248) levels were similar in both groups. Although hs-CRP was higher in Group 1 (90.45 ± 46.67 vs. 72.91 ± 57.31 mg/L) this had no statistical significance. Clinical outcomes have been in positive correlations with inflammation, but statistically insignificant in both groups. Conclusion: Monitoring of IL-6 and hs-CRP during redo CABG has shown that CPB cause inflammatory reaction but repeated use does not cause extensive reaction potentially harmful for myocardium.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.